In patients with advanced Claudin-18 isoform 2 (CLDN18.2) -positive gastric or gastroesophageal junction cancers, satricabtagene autoleucel (satri-cel) chimeric antigen receptor (CAR) T-cell therapy ...

Twelve people whose stomach or colon cancers had defeated every available treatment were infused with their own immune cells, ...

Working with an international team of collaborators, scientists at Columbia University have found a way to shift the balance of a type of white blood cell inside a stomach tumor, causing the immune ...

Quadrant of co-occurrence of circulating tumor DNA and PD-L1 expression on circulating tumor cells in monitoring disease aggressiveness and metastasis in lung cancer. This is an ASCO Meeting Abstract ...

A recent study published in Cell Reports Medicine has identified distinct microbial signatures within the oral cavity and gut that serve as robust biomarkers for the early detection of gastric cancer ...

Researchers have found that a cancer outside the brain makes electrical connections with the nervous system to fuel cancer growth and aid its spread. Researchers have discovered that stomach cancers ...

Reviewed by Anuj K. Patel, MD, Clinical Director of the Center for Esophageal and Gastric Cancer at the Dana-Farber Cancer Institute and Assistant Professor of Medicine at Harvard Medical School in ...

Gastric cancer is one of the leading causes of cancer-related mortality worldwide, and peritoneal metastasis, wherein the cancer spreads to the peritoneum or the lining of the abdominal cavity, ...

Stomach cancer is challenging to detect early due to vague symptoms, often diagnosed at advanced stages. Diagnosis involves endoscopy, imaging, laparoscopy, and molecular testing for markers like HER2 ...